KoBioLabs said on Tuesday that it has signed a memorandum of understanding (MOU) for a comprehensive business partnership with Kakao Healthcare to develop precision and personalized medicine and nutritional solutions using microbiome technology.

Under the MOU, the two companies will enhance user accessibility and create various related value-added businesses by presenting a differentiated digital bio-healthcare platform using KoBioLab's unique real data and expertise.

The human microbiome can function as an important indicator in presenting advanced customized medical and nutritional solutions as it is associated with various chronic diseases like cancer.

The combination of know-how and data from KoBioLab and Kakao Healthcare's digital platform technology is expected to provide delicate and sophisticated solutions for personalized health care. 

Additionally, Kakao Healthcare is actively expanding the digital healthcare ecosystem and is actively collaborating with hospitals and major healthcare companies.

An official from KoBioLabs said, "We expect Kakao Healthcare's mobile, artificial intelligence, and medical information-related technologies to present individual digital bio-healthcare solutions with international competitiveness by combining the microbiome platform technology and know-how accumulated over the years."